| pubmed-article:20451663 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0010346 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0205081 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C1872109 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:20451663 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:20451663 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:20451663 | pubmed:dateCreated | 2010-8-2 | lld:pubmed |
| pubmed-article:20451663 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:abstractText | Patients with moderate to severe Crohn's disease who receive infliximab may experience secondary failure (loss of response and/or hypersensitivity). Data on the utility of switching to certolizumab pegol in these patients are limited. | lld:pubmed |
| pubmed-article:20451663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20451663 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20451663 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20451663 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:20451663 | pubmed:issn | 1542-7714 | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:RutgeertsPaul... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:D'HaensGeertG | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:SandbornWilli... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:FedorakRichar... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:ColombelJean-... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:AbreuMaria... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:VermeireSever... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:WolfDouglas... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:MitchevKrassi... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:LeeScottS | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:SpehlmannMart... | lld:pubmed |
| pubmed-article:20451663 | pubmed:author | pubmed-author:JamoulCorinne... | lld:pubmed |
| pubmed-article:20451663 | pubmed:copyrightInfo | Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20451663 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20451663 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:20451663 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20451663 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20451663 | pubmed:pagination | 688-695.e2 | lld:pubmed |
| pubmed-article:20451663 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:meshHeading | pubmed-meshheading:20451663... | lld:pubmed |
| pubmed-article:20451663 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20451663 | pubmed:articleTitle | Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab. | lld:pubmed |
| pubmed-article:20451663 | pubmed:affiliation | Mayo Clinic, Rochester, Minnesota, USA. | lld:pubmed |
| pubmed-article:20451663 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20451663 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20451663 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20451663 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20451663 | lld:pubmed |
